<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01811017</url>
  </required_header>
  <id_info>
    <org_study_id>CYN12-PICO_MGH_TB</org_study_id>
    <nct_id>NCT01811017</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of 755nm Alexandrite Laser Versus Nanosecond 755nm Alexandrite</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cynosure, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cynosure, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Compare the efficacy of the 755nm Alexandrite laser to the nanosecond 755nm Alexandrite laser
      for the removal of unwanted tattoos using photographic evaluation and histological findings.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Actual">May 2013</completion_date>
  <primary_completion_date type="Actual">May 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Photographic Evaluation of Tattoo Clearance</measure>
    <time_frame>up to 3 months post last treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subject biopsy sampling</measure>
    <time_frame>up to 3 months post last treatment</time_frame>
    <description>Histological evaluation of tissue samples pre-treatment and post-treatment</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Number of participants with adverse events as a measure of safety and tolerability</measure>
    <time_frame>up to 3 months post last treatment</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Tattoos</condition>
  <arm_group>
    <arm_group_label>755nm Alexandrite Laser</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>755nm Alexandrite Laser</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nanosecond 755nm Alexandrite Laser</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nanosecond 755nm Alexandrite Laser</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>755nm Alexandrite Laser</intervention_name>
    <description>755nm Alexandrite Laser</description>
    <arm_group_label>755nm Alexandrite Laser</arm_group_label>
    <arm_group_label>Nanosecond 755nm Alexandrite Laser</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Is a healthy male or female between 18 and 85 years old?

          2. Has unwanted non-cosmetic tattoo(s) and wishes to undergo laser treatments

          3. Is willing to consent to participate in the study.

          4. Is willing to shield the tattoo completely from sun exposure

          5. Signs informed consent form

          6. Is willing to comply with all requirements of the study including being photographed,
             following post treatment care and attending all treatment and follow up visits.

        Exclusion Criteria:

          1. Subjects who are unwilling to consent to tattoos

          2. Subjects mentally ill or incompetent

          3. Subjects is unwilling to have photographs taken and used in publications or scientific
             presentations

          4. Subjects who are prisoners

          5. Subjects with recent sun exposure and suntan in the area to be treated

          6. Allergic tattoos (hypersensitivity to tattoo ink)

          7. History of vitiligo or keloidal scarring

          8. Tattoos located on the neck or face including cosmetic tattoos

          9. Subjects unwilling to tolerate partial removal of the tattoo in this study

         10. Infection or skin disease in the area to be treated

         11. Subjects who are immunosuppressed (e.g. HIV)

         12. Subject is pregnant or nursing

         13. Use of oral isotretinoin within past 12 months

         14. History of squamous cell carcinoma or melanoma

         15. Is allergic to Lidocaine, tetracaine or Xylocaine with epinephrine.

         16. Has any other reason determined by the physician to be ineligible to participate in
             the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patricia Krantz</last_name>
    <role>Study Director</role>
    <affiliation>Cynosure, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Boston Va Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02130</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 6, 2012</study_first_submitted>
  <study_first_submitted_qc>March 12, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 14, 2013</study_first_posted>
  <last_update_submitted>February 3, 2014</last_update_submitted>
  <last_update_submitted_qc>February 3, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 5, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

